Literature DB >> 4290687

Metabolism of vitamin D3-3H in human subjects: distribution in blood, bile, feces, and urine.

L V Avioli, S W Lee, J E McDonald, J Lund, H F DeLuca.   

Abstract

Vitamin D(3)-(3)H has been administered intravenously to seven normal subjects, three patients with biliary fistulas, and four patients with cirrhosis. Plasma D(3)-(3)H half-times normally ranged from 20 to 30 hours. in vivo evidence that a metabolic transformation of vitamin D occurs was obtained, and a polar biologically active vitamin D metabolite was isolated from plasma. Urinary radioactivity averaged 2.4% of the administered dose for the 48-hour period after infusion, and all the excreted radioactivity represented chemically altered metabolites of vitamin D. The metabolites in urine were mainly water-soluble, with 26% in conjugated form. From 3 to 6% of the injected radioactivity was excreted in the bile of subjects with T-tube drainage and 5% in the feces of patients having no T-tube. The pattern of fecal and biliary radioactivity suggested that the passage of vitamin D and its metabolites from bile into the intestine represents an essential stage for the fecal excretion of vitamin D metabolites in man. Abnormally slow plasma disappearance of vitamin D(3)-(3)H in patients with cirrhosis was associated with a significant decrease in the quantity and rate of glucuronide metabolite excretion in the urine.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4290687      PMCID: PMC297103          DOI: 10.1172/JCI105605

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

1.  THE PREPARATION OF H3-VITAMINS D2 AND D3--THEIR LOCALIZATION IN THE RAT.

Authors:  A W NORMAN; H F DELUCA
Journal:  Biochemistry       Date:  1963 Sep-Oct       Impact factor: 3.162

2.  BIOLOGICALLY ACTIVE FORMS OF VITAMIN D3 IN KIDNEY AND INTESTINE.

Authors:  A W NORMAN; J LUND; H F DELUCA
Journal:  Arch Biochem Biophys       Date:  1964-10       Impact factor: 4.013

3.  Tracer studies of the absorption and fate of steroid hormones in man.

Authors:  H L BRADLOW; E L FRAZELL; T F GALLAGHER; L HELLMAN
Journal:  J Clin Invest       Date:  1956-09       Impact factor: 14.808

4.  Malabsorption and bone disease in prolonged obstructive jaundice.

Authors:  M ATKINSON; B E NORDIN; S SHERLOCK
Journal:  Q J Med       Date:  1956-07

5.  The preparation and properties of beta-glucuronidase. IV. Inhibition by sugar acids and their lactones.

Authors:  G A LEVVY
Journal:  Biochem J       Date:  1952-11       Impact factor: 3.857

6.  Metabolism of tritiated vitamin D.

Authors:  R K Callow; E Kodicek; G A Thompson
Journal:  Proc R Soc Lond B Biol Sci       Date:  1966-02-15

7.  The synthesis of [1,2-3H]vitamin D3 and the tissue localization of a 0.25-mu-g (10 IU) dose per rat.

Authors:  P F Neville; H F DeLuca
Journal:  Biochemistry       Date:  1966-07       Impact factor: 3.162

8.  Absorption of vitamin D3-3H in control subjects and patients with intestinal malabsorption.

Authors:  G R Thompson; B Lewis; C C Booth
Journal:  J Clin Invest       Date:  1966-01       Impact factor: 14.808

9.  Biologically active metabolite of vitamin D3 from bone, liver, and blood serum.

Authors:  J Lund; H F DeLuca
Journal:  J Lipid Res       Date:  1966-11       Impact factor: 5.922

10.  Actinomycin D Inhibition of Vitamin D Action.

Authors:  J E Zull; E Czarnowska-Misztal; H F Deluca
Journal:  Science       Date:  1965-07-09       Impact factor: 47.728

View more
  38 in total

Review 1.  Clinical review: The role of the parent compound vitamin D with respect to metabolism and function: Why clinical dose intervals can affect clinical outcomes.

Authors:  Bruce W Hollis; Carol L Wagner
Journal:  J Clin Endocrinol Metab       Date:  2013-10-08       Impact factor: 5.958

2.  Abnormal vitamin D metabolism in cirrhosis.

Authors:  R T Jung; M Davie; J O Hunter; T M Chalmers; D E Lawson
Journal:  Gut       Date:  1978-04       Impact factor: 23.059

Review 3.  The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).

Authors:  Luisella Cianferotti; Claudio Cricelli; John A Kanis; Ranuccio Nuti; Jean-Y Reginster; Johann D Ringe; Rene Rizzoli; Maria Luisa Brandi
Journal:  Endocrine       Date:  2015-05-01       Impact factor: 3.633

4.  Metabolic profiling of major vitamin D metabolites using Diels-Alder derivatization and ultra-performance liquid chromatography-tandem mass spectrometry.

Authors:  Pavel A Aronov; Laura M Hall; Katja Dettmer; Charles B Stephensen; Bruce D Hammock
Journal:  Anal Bioanal Chem       Date:  2008-04-24       Impact factor: 4.142

Review 5.  Vitamin D metabolism. Recent advances.

Authors:  T C Stamp
Journal:  Arch Dis Child       Date:  1973-01       Impact factor: 3.791

6.  Effect of cholestyramine on the absorption of vitamin D3 and calcium.

Authors:  W G Thompson; G R Thompson
Journal:  Gut       Date:  1969-09       Impact factor: 23.059

7.  The role of the liver in the metabolism of vitamin D.

Authors:  G Ponchon; H F DeLuca
Journal:  J Clin Invest       Date:  1969-07       Impact factor: 14.808

8.  Comparative absorption of vitamin D3 and 25-hydroxyvitamin D3 in intestinal disease.

Authors:  M Davies; E B Mawer; E L Krawitt
Journal:  Gut       Date:  1980-04       Impact factor: 23.059

9.  Role of vitamin D glucosiduronate in calcium homeostasis.

Authors:  S Nagubandi; R Kumar; J M Londowski; R A Corradino; P S Tietz
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

10.  Human plasma transport of vitamin D after its endogenous synthesis.

Authors:  J G Haddad; L Y Matsuoka; B W Hollis; Y Z Hu; J Wortsman
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.